This site is currently in BETA testing mode.

Send us your feedback!

Breakthrough drug trial aims to cure chronic hepatitis b

NCT ID NCT05630820

ACTIVE_NOT_RECRUITING ⭐️ CURE ⭐️ Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This large, late-stage study is testing whether a drug called bepirovirsen can provide a 'functional cure' for people with chronic Hepatitis B. It involves 857 participants who are already on standard medication. The main goal is to see if the treatment can suppress the virus to undetectable levels and allow patients to safely stop all medications long-term.

Contacts and locations

Locations

  • GSK Investigational Site

    Centreville, Alabama, 35042, United States

  • GSK Investigational Site

    Los Angeles, California, 90033, United States

  • GSK Investigational Site

    San Francisco, California, 94115, United States

  • GSK Investigational Site

    San Francisco, California, 94121, United States

  • GSK Investigational Site

    Colorado Springs, Colorado, 80907, United States

  • GSK Investigational Site

    Ft. Pierce, Florida, 34982, United States

  • GSK Investigational Site

    Miami, Florida, 33136, United States

  • GSK Investigational Site

    Glen Burnie, Maryland, 21061, United States

  • GSK Investigational Site

    Minneapolis, Minnesota, 55404, United States

  • GSK Investigational Site

    Philadelphia, Pennsylvania, 19104, United States

  • GSK Investigational Site

    Denison, Texas, 75020, United States

  • GSK Investigational Site

    Seattle, Washington, 98104, United States

  • GSK Investigational Site

    Buenos Aires, 1023, Argentina

  • GSK Investigational Site

    Buenos Aires, C1425AGC, Argentina

  • GSK Investigational Site

    Ciudad Autonoma de Bueno, C1056ABI, Argentina

  • GSK Investigational Site

    Santa Fe, 3000, Argentina

  • GSK Investigational Site

    Westmead, New South Wales, 2145, Australia

  • GSK Investigational Site

    Herston, Queensland, 4029, Australia

  • GSK Investigational Site

    Box Hill, Victoria, 3128, Australia

  • GSK Investigational Site

    Fitzroy, Victoria, 3065, Australia

  • GSK Investigational Site

    Botucatu, 18618-686, Brazil

  • GSK Investigational Site

    Fortaleza, 60430-372, Brazil

  • GSK Investigational Site

    Nova Iguaçu, 26030-380, Brazil

  • GSK Investigational Site

    Porto Alegre, 90020-090, Brazil

  • GSK Investigational Site

    Porto Alegre, 90035003, Brazil

  • GSK Investigational Site

    Rio de Janeiro, 21045-900, Brazil

  • GSK Investigational Site

    Salvador, 40110160, Brazil

  • GSK Investigational Site

    Vitória, 29043260, Brazil

  • GSK Investigational Site

    Plovdiv, 4002, Bulgaria

  • GSK Investigational Site

    Sliven, 8800, Bulgaria

  • GSK Investigational Site

    Sofia, 1797, Bulgaria

  • GSK Investigational Site

    Varna, 9020, Bulgaria

  • GSK Investigational Site

    Calgary, Alberta, T2N 4N1, Canada

  • GSK Investigational Site

    Edmonton, Alberta, T6G 2B7, Canada

  • GSK Investigational Site

    Edmonton, Alberta, T6G 2X8, Canada

  • GSK Investigational Site

    Halifax, Nova Scotia, B3H 2Y9, Canada

  • GSK Investigational Site

    Toronto, Ontario, M6H 3M1, Canada

  • GSK Investigational Site

    Montreal, Quebec, H2L 4E9, Canada

  • GSK Investigational Site

    Montreal, Quebec, H2L 4P9, Canada

  • GSK Investigational Site

    Regina, Saskatchewan, S4P 0W5, Canada

  • GSK Investigational Site

    Beijing, 100015, China

  • GSK Investigational Site

    Beijing, 100032, China

  • GSK Investigational Site

    Changchun, 130021, China

  • GSK Investigational Site

    Chengdu, 610072, China

  • GSK Investigational Site

    Chongqing, 400042, China

  • GSK Investigational Site

    Guangzhou, 510515, China

  • GSK Investigational Site

    Guangzhou, 510630, China

  • GSK Investigational Site

    Hangzhou, 310000, China

  • GSK Investigational Site

    Hangzhou, 310003, China

  • GSK Investigational Site

    Hefei, 230022, China

  • GSK Investigational Site

    Kunming, 650021, China

  • GSK Investigational Site

    Liuchow, China

  • GSK Investigational Site

    Nanjing, 210003, China

  • GSK Investigational Site

    Shanghai, 200025, China

  • GSK Investigational Site

    Shanghai, 200052, China

  • GSK Investigational Site

    Shenzhen, 518023, China

  • GSK Investigational Site

    Taiyuan, 030001, China

  • GSK Investigational Site

    Tianjin, 300000, China

  • GSK Investigational Site

    Ürümqi, 830054, China

  • GSK Investigational Site

    Wuhan, 430022, China

  • GSK Investigational Site

    Xi'an, 710061, China

  • GSK Investigational Site

    Xiamen, 361015, China

  • GSK Investigational Site

    Zhengzhou, 450000, China

  • GSK Investigational Site

    Zunyi, 563114, China

  • GSK Investigational Site

    Créteil, 94010, France

  • GSK Investigational Site

    Grenoble, 38043, France

  • GSK Investigational Site

    Limoges, 87042, France

  • GSK Investigational Site

    Lyon, 69317, France

  • GSK Investigational Site

    Paris, 75651, France

  • GSK Investigational Site

    Rouen, 76031, France

  • GSK Investigational Site

    Toulouse, 31059, France

  • GSK Investigational Site

    Frankfurt, 60329, Germany

  • GSK Investigational Site

    Frankfurt, 60596, Germany

  • GSK Investigational Site

    Hamburg, 20146, Germany

  • GSK Investigational Site

    Hanover, 30625, Germany

  • GSK Investigational Site

    Athens, 115 27, Greece

  • GSK Investigational Site

    Heraklion Crete, 715 00, Greece

  • GSK Investigational Site

    Thessaloniki, 54642, Greece

  • GSK Investigational Site

    Szeged, 6725, Hungary

  • GSK Investigational Site

    Székesfehérvár, 8000, Hungary

  • GSK Investigational Site

    Zalaegerszeg, Hungary

  • GSK Investigational Site

    Ahmedabad, 380009, India

  • GSK Investigational Site

    Chennai, 600035, India

  • GSK Investigational Site

    Kanpur, 208002, India

  • GSK Investigational Site

    Kochi, 682026, India

  • GSK Investigational Site

    Kolkata, 700150, India

  • GSK Investigational Site

    Kolkata, India

  • GSK Investigational Site

    Mumbai, 400012, India

  • GSK Investigational Site

    Mumbai, 400022, India

  • GSK Investigational Site

    Nagpur, 441108, India

  • GSK Investigational Site

    New Delhi, 110029, India

  • GSK Investigational Site

    New Delhi, 110060, India

  • GSK Investigational Site

    New Delhi, 110070, India

  • GSK Investigational Site

    Pune, 411001, India

  • GSK Investigational Site

    Raipur, India

  • GSK Investigational Site

    Secunderabad, 500003, India

  • GSK Investigational Site

    Milan, 20157, Italy

  • GSK Investigational Site

    Napoli, 80131, Italy

  • GSK Investigational Site

    Padua, 35128, Italy

  • GSK Investigational Site

    Palermo, 90127, Italy

  • GSK Investigational Site

    Pisa, 56124, Italy

  • GSK Investigational Site

    Roma, 00133, Italy

  • GSK Investigational Site

    Sassari, 07100, Italy

  • GSK Investigational Site

    Torino, 10126, Italy

  • GSK Investigational Site

    Fukui, 918-8503, Japan

  • GSK Investigational Site

    Hiroshima, 730-8619, Japan

  • GSK Investigational Site

    Hokkaido, 006-8555, Japan

  • GSK Investigational Site

    Hokkaido, 060-8648, Japan

  • GSK Investigational Site

    Hokkaido, 062-8618, Japan

  • GSK Investigational Site

    Ishikawa, 920-8650, Japan

  • GSK Investigational Site

    Kagawa, 760-8557, Japan

  • GSK Investigational Site

    Kumamoto, 860-8556, Japan

  • GSK Investigational Site

    Nagasaki, 856-8562, Japan

  • GSK Investigational Site

    Nara, 634-8522, Japan

  • GSK Investigational Site

    Niigata, 950-1104, Japan

  • GSK Investigational Site

    Osaka, 565-0871, Japan

  • GSK Investigational Site

    Tokyo, 113-8603, Japan

  • GSK Investigational Site

    Yamaguchi, 750-0061, Japan

  • GSK Investigational Site

    Yamanashi, 409-3898, Japan

  • GSK Investigational Site

    Johor Bahru, 80100, Malaysia

  • GSK Investigational Site

    Kota Bharu Kelantan, Malaysia

  • GSK Investigational Site

    Kota Kinabalu, Malaysia

  • GSK Investigational Site

    Kuala Lumpur, 59100, Malaysia

  • GSK Investigational Site

    Kuala Terengganu, 20400, Malaysia

  • GSK Investigational Site

    Kuantan, 25100, Malaysia

  • GSK Investigational Site

    Aguascalientes, 20010, Mexico

  • GSK Investigational Site

    Auckland, 1023, New Zealand

  • GSK Investigational Site

    Papatoetoe Auckland, 2025, New Zealand

  • GSK Investigational Site

    Panama City, Panama

  • GSK Investigational Site

    Cebu City, 6000, Philippines

  • GSK Investigational Site

    Makati City, 1229, Philippines

  • GSK Investigational Site

    Pasig, 1605, Philippines

  • GSK Investigational Site

    Silang, 4118, Philippines

  • GSK Investigational Site

    Gdansk, 80-405, Poland

  • GSK Investigational Site

    Mysłowice, 41-400, Poland

  • GSK Investigational Site

    Żychlin, 62-571, Poland

  • GSK Investigational Site

    Bucharest, 020475, Romania

  • GSK Investigational Site

    Bucharest, 030303, Romania

  • GSK Investigational Site

    Cluj-Napoca, 400348, Romania

  • GSK Investigational Site

    Constanța, 900709, Romania

  • GSK Investigational Site

    Galati, 800179, Romania

  • GSK Investigational Site

    Oradea, 410469, Romania

  • GSK Investigational Site

    Ansan, 15355, South Korea

  • GSK Investigational Site

    Incheon, 405-760, South Korea

  • GSK Investigational Site

    Pusan, 49241, South Korea

  • GSK Investigational Site

    Seoul, 03312, South Korea

  • GSK Investigational Site

    Seoul, 05505, South Korea

  • GSK Investigational Site

    Ulsan, 44033, South Korea

  • GSK Investigational Site

    Alcorcon Madrid, Spain

  • GSK Investigational Site

    Badajoz, 06080, Spain

  • GSK Investigational Site

    Granada, 18016, Spain

  • GSK Investigational Site

    Madrid, 28006, Spain

  • GSK Investigational Site

    Madrid, 28032, Spain

  • GSK Investigational Site

    Madrid, 28046, Spain

  • GSK Investigational Site

    Sabadell Barcelona, 08208, Spain

  • GSK Investigational Site

    Seville, 41013, Spain

  • GSK Investigational Site

    Valencia, 46026, Spain

  • GSK Investigational Site

    Valladolid, 47012, Spain

  • GSK Investigational Site

    Zaragoza, 50009, Spain

  • GSK Investigational Site

    Kaohsiung City, 824, Taiwan

  • GSK Investigational Site

    Taichung, 404, Taiwan

  • GSK Investigational Site

    Tainan, 704, Taiwan

  • GSK Investigational Site

    Taipei, 100, Taiwan

  • GSK Investigational Site

    Chiang Mai, 50200, Thailand

  • GSK Investigational Site

    Ankara, 06590, Turkey (Türkiye)

  • GSK Investigational Site

    Istanbul, 34010, Turkey (Türkiye)

  • GSK Investigational Site

    Izmir, 35100, Turkey (Türkiye)

  • GSK Investigational Site

    Liverpool, L7 8XP, United Kingdom

  • GSK Investigational Site

    London, WC1E 6JB, United Kingdom

  • GSK Investigational Site

    Middlesbrough, TS4 3BW, United Kingdom

  • GSK Investigational Site

    Newcastle upon Tyne, NE7 7DN, United Kingdom